Pharmafile Logo
Pharmafocus logo
Advanced Search

Contract research news in brief

February 23, 2011
Research and Development Bioanalytical Systems, Evotec, Iris Pharma, Kancera, Kinaxo Biotechnologies, NSF International, Pharmalytica Services, iNovacia

Acquisitions by Evotec, Kancera and NSF International head our latest CRO news round-up, along with updates from BASi and Iris …

News

Sanofi partners on dengue vaccine awareness

February 22, 2011
Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines

Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …

News

Scottish biotech ProStrakan sold for £292m

February 22, 2011
Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech

Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …

News

Pharma must rethink manufacturing, says PwC

February 22, 2011
Manufacturing and Production pharma manufacturing, pricewaterhousecoopers, pwC

The pharmaceutical industry needs to undertake a radical overhaul in its approach to manufacturing which at present is “inefficient, under-utilised …

News

AstraZeneca plans $150m plant in Russia

February 22, 2011
Manufacturing and Production, Sales and Marketing AstraZeneca, Russia, emerging pharma markets, pharma manufacturing

AstraZeneca has become the latest drugmaker to announce the construction of a manufacturing facility in Russia to help sidestep possible …

News

Quality problems lead to short-term layoffs at Baxter Ireland

February 22, 2011
Manufacturing and Production Dianeal, Extraneal, Ireland, Nutrineal, baxter, job cuts, manufacturing compliance, peritoneal dialysis

A contaminated production line at a facility in Ireland operated by Baxter Healthcare has resulted in 150 staff being laid …

News
oxford_biomedica__manufacturing_james_christie

James Christie joins Oxford BioMedica as manufacturing head

February 22, 2011
Manufacturing and Production James Christie, Oxford BioMedica, appointment, manufacturing and production

UK gene therapy company Oxford BioMedica has appointed James Christie as its first head of manufacturing. It following the firm’s …

Appointment

SHL to speak at Drug Delivery System Development and Lifecycle Management Requirements for Biologic Pharmaceuticals: Trends and Best Practices

February 22, 2011
Manufacturing and Production auto injector, autoinjector, drug delivery, shl group

The 2011 DCAT Biologics Forum will focus on trends and best practices for subcutaneous biologic drug delivery systems featuring presentations …

News
Press release
Counterfeit Plavix

Europe votes in new anti-counterfeit law

February 21, 2011
Manufacturing and Production EFPIA, counterfeits, supply chain

The European Parliament has voted in favour of the Falsified Medicines Directive to help stop the flow of counterfeit medicines …

News

Four steps to turn around a flagging pharma brand

February 21, 2011
Sales and Marketing MSI, branding, brands, marketing

The glamorous end of pharma marketing is undoubtedly around the launch of a new product. Everyone is excited and optimistic, …

Feature
idea_michael_morgan-curran

Idea Pharma boosts UK and US teams

February 21, 2011
Sales and Marketing IDEA Pharma, Jeff Frick, Michael Morgan-Curran, appointment, sales and marketing

Idea Pharma has made new appointments to its UK- and US-based teams

Appointment

Astellas to commercialise new kidney cancer drug in Europe

February 21, 2011
Sales and Marketing Astellas, Aveo Pharmaceuticals, Cancer, Kidney cancer, rcc, renal cell carcinoma, tivozanib

Astellas and Aveo Pharmaceuticals are to commercialise Aveo’s investigational kidney cancer drug tivozanib in Europe and the US. Aveo is …

News

J&J hit by another string of product recalls

February 21, 2011
Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls

There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …

News
Merck KGaA

Merck KGaA sales soar

February 21, 2011
Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro

Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …

News

Matt de Gruchy to lead Ogilvy Healthworld UK

February 18, 2011
Medical Communications Matt de Gruchy, Ogilvy Healthworld UK, appointment, medical communications

Comms agency Ogilvy Healthworld UK has appointed Matt de Gruchy as chief executive. Matt is a 14 year veteran of …

Appointment
Blog footer

Digital Pharma: Merck Serono sets up MS social network

February 18, 2011
Medical Communications Digital Pharma blog, MS, Merck Serono, Movectro, Rebif, multiple sclerosis, social networking

Merck Serono has set up an international social network for multiple sclerosis patients, saying today’s pharma companies should go beyond …

News
Merck Serono headquarters

Merck Serono halts Movectro European licence application

February 18, 2011
Medical Communications, Sales and Marketing Cladribine, MS, Merck KGaA, Merck Serono, Movectro, fingolimod, gilenya, multiple sclerosis

Merck Serono has withdrawn its European licence application for multiple sclerosis drug Movectro. Movectro (cladribine) is a new oral treatment …

News

Value-based pricing will not harm industry, says NICE chief

February 18, 2011
Sales and Marketing Health Select Committee, Health and Social Care Bill, NHS reform, NICE, Sir Andrew Dillon, value-based pricing

NICE’s chief executive Sir Andrew Dillon says he believes plans to introduce value-based pricing of medicines will not have a …

News

AZ accepts $92.5m to settle respiratory dispute

February 18, 2011
Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory

AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …

News

Trial failures threaten UK biotech

February 18, 2011
Research and Development AML, AS1411, AS1413, Antisoma, Juvista, Renovo, UK biotech, acute myeloid leukaemia, anti-scarring, biotech

A number of late stage failures from British biotech firms have left a looming question mark over the future of …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026